Omnicell to Release Third Quarter 2013 Earnings Results on October 31

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

MOUNTAIN VIEW, Calif., Oct. 24, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities,will hold a conference call Thursday, October 31, to discuss the Company's Third Quarter 2013 financial results.

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

What:

Omnicell Third Quarter 2013 earnings conference call and webcast

When:

October 31, 2013, 1:30 p.m. PT

Who:

Randall Lipps, chairman, president and chief executive officer


Rob Seim, chief financial officer

Where:

The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 86848569.


The webcast can be accessed at: http://ir.omnicell.com/events.cfm.





How:

Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.

Replay:

Available starting at 4:30 p.m. PT on October 31, 2013 through 12:00 p.m. PT on November 14, 2013. Dial

1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 86848569.

About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.

More than 2,600 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.

OMCL-E

For more information:
Rob Seim Omnicell, Inc.
Chief Financial Officer
800-850-6664, ext. 6478
rob.seim@omnicell.com

SOURCE Omnicell, Inc.



Help employers find you! Check out all the jobs and post your resume.

Back to news